Fisher & Paykel Healthcare Limited
$1.1M 25 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Avanos Medical
Avanos Medical reported $1,128,673.99 across General Payments, Research, and Ownership to 3,846 physicians and teaching hospitals across 3,887 transactions.
- $1.1M
- All-tracks total
- 3,887
- Transactions
- 3,846
- Recipients
- +$229.1K
- General Payments vs PY2023
Avanos Medical reported $1,128,673.99 across all CMS Open Payments tracks (General + Research + Ownership) to 3,846 physicians and teaching hospitals in Program Year 2024 - ranking #593 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $867,206.49, averaging $293.47 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer avanos-medical Avanos Medical
$1.1M · #593/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #593
- SHARE 0.0%
- TXN 3,887
- RCP 3,846
- CAT 5
- GEN $867.2K
- ΔGEN +$229.1K
- TOP1 6.9%
- PY 2024
Volume peers
Nearest volume peer: Fisher & Paykel Healthcare Limited ($1.1M)
Avanos Medical sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Avanos Medical's CMS-reported General Payments increased by $229.1K (+35.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AVANOS MEDICALPY2023: AVANOS MEDICALPY2024: Avanos Medical. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $638,059.31
- PY2024
- $867,206.49
What the Data Shows for Avanos Medical
In Program Year 2024, Avanos Medical reported $1,128,673.99 in payments to 3,846 physicians and teaching hospitals across 3,887 individual transactions, an average of $290.37 per transaction and $293.47 per recipient. That total places Avanos Medical at rank #593 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $643.1K, accounting for 74.2% of this company's General Payments and 183 transactions.
General Payment Breakdown by Type
"Honoraria" leads Avanos Medical's 5-category general-payment breakdown at $643.1K, 74.2% of the reported total.
Avanos Medical reports 5 general-payment categories - the top three are Honoraria (74.2%), Food and Beverage (16.0%), and Travel and Lodging (9.8%). The remaining 2 categories make up 0.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Avanos Medical divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $643.1K | 183 | 74.2% |
| Food and Beverage | $138.5K | 3,399 | 16.0% |
| Travel and Lodging | $85.1K | 258 | 9.8% |
| Consulting Fee | $455.57 | 5 | 0.1% |
| Gift | $23.56 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $243,275.23 (28.1%) of $867,206.49 in this company's General Payments records across 2,714 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Avanos Medical
The five named recipients with the highest reported General Payments from this company
- 1
Felix Gonzalez
$59,404.98 across 41 reported transactions
- 2
Rajiv Tewari
$51,297.97 across 52 reported transactions
- 3
Maxim Eckmann
$46,898.23 across 40 reported transactions
- 4
Alaa Abd-Elsayed
$43,371.44 across 26 reported transactions
- 5
Sandeep Amin
$42,302.61 across 37 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Avanos Medical's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Avanos Medical.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Avanos Medical.
Showing 6 of 1,924 companies with CMS-reported payment data.
Medartis Inc.
$1.1M 504 recipients
Compare payment profiles
Gynesonics, Inc.
$1.1M 2,114 recipients
Compare payment profiles
Arrow International, Inc.
$1.1M 184 recipients
Compare payment profiles
Guard Medical SAS
$1.1M 0 recipients
Compare payment profiles
Ossio Ltd
$1.1M 0 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.